Holen Sie sich die Stockscreener-App
86.68
0.82%
-0.72
Vorhandelsmarkt:
86.68
Schlusskurs vom Vortag:
$87.40
Offen:
$86.93
24-Stunden-Volumen:
80,013
Relative Volume:
0.57
Marktkapitalisierung:
$1.11B
Einnahmen:
$86.28M
Nettoeinkommen (Verlust:
$23.61M
KGV:
47.21
EPS:
1.8359
Netto-Cashflow:
$23.97M
1W Leistung:
-0.55%
1M Leistung:
-10.67%
6M Leistung:
-16.30%
1J Leistung:
+24.15%
1-Tages-Spanne:
$86.60
$88.52
1-Wochen-Bereich:
$85.00
$89.03
52-Wochen-Spanne:
$67.84
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
86.68 | 1.12B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
114.14 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
327.70 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.30 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.37 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.83 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
Rice Hall James & Associates LLC Invests $2.91 Million in iRadimed Corporation $IRMD - MarketBeat
Form 8K Iradimed Co For: 18 August By Investing.com - Investing.com UK
iRadimed (NASDAQ:IRMD) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
IRMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - webull.com
iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen - MarketBeat
Iradimed Stock Price Forecast. Should You Buy IRMD? - StockInvest.us
How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors - Yahoo Finance
Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth - Yahoo Finance
Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD) - simplywall.st
IRadimed Corp Earnings Call Highlights Ramp, Resilience - TipRanks
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... By GuruFocus - Investing.com Canada
IRADIMED (IRMD) Stock Drops As 3870 Ramp Cuts Gross Margin - Sahm
iRadimed (NASDAQ:IRMD) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
IRadimed Corp reports results for the quarter ended June 30Earnings Summary - tradingview.com
Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins - Investing.com
IRADIMED ($IRMD) Releases Q2 2026 Earnings - Quiver Quantitative
IRadimed: Q2 Earnings Snapshot - kens5.com
iRadimed (NASDAQ:IRMD) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Iradimed earnings on deck as growth momentum faces Q2 test - Investing.com
Record Results, New MRI Pump And Dividend Hike Might Change The Case For Investing In IRADIMED (IRMD) - Sahm
Renaissance Technologies LLC Sells 15,700 Shares of iRadimed Corporation $IRMD - MarketBeat
iRadimed (IRMD) Still Has a High-Quality Niche Story, but the Valuation Debate Is Getting Harder - AlphaStreet
Iradimed Corporation (IRMD) Sales Reflects The Fund’s Valuation and Sizing Discipline - Yahoo Finance
IRadimed Corp (IRMD) Institutional Confidence - TradingKey
IRadimed Corp (IRMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRadimed Corp (IRMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
IRadimed Corp (IRMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRadimed Corp (IRMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
IRadimed Corp (IRMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
IRMD|IRadimed Corp|Price:94.860|Chg%:+0.370 - TradingKey
IRadimed Corp (IRMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRMD|IRadimed Corp|Price:94.490|Chg%:+0.630 - TradingKey
IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026 - The Manila Times
Before market open, IRADIMED will release Q2 results July 31 - Stock Titan
iRadimed (IRMD) Expected to Post Earnings on Thursday - MarketBeat
IRADIMED (IRMD) As MRI Pump Upgrade Narrative Points To Fair Value Above The Stock - Sahm
IRADIMED CORPORATION (IRMD) Options Chain - Yahoo! Finance Canada
Iradimed Corp (IRMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Copeland Capital Management LLC Sells 53,225 Shares of iRadimed Corporation $IRMD - MarketBeat
iRadimed (IRMD) Q1 2026 Earnings: EPS Surprise Beats Estimates, Revenue Details Not DisclosedPeak Earnings Alert - po-news-eg.net
Price to book forward of IRadimed Corp. – LS:A118V4 - TradingView
IRADIMED CORP (IRMD) Stock Chart - ChartMill
IRMDIradimed Corp Latest SEC Filings - Finviz
Price to book forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to EBITDA forward of IRadimed Corp. – HAN:46K - TradingView
Enterprise value to revenue forward of IRadimed Corp. – HAN:46K - TradingView
IRadimed Corp. Actuals & Estimates (DUS:46K) - TradingView
IRadimed Corp. Actuals & Estimates (NASDAQ:IRMD) - TradingView
46K Forecast — Price Target — Prediction for 2027 - TradingView
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):